
Marvell Technology agreed to acquire optical components maker Lumentum in an all-stock transaction that values Lumentum at an enterprise value of $115 billion. Shares of both companies fell by more than 10% after the November 2 announcement.
Each Lumentum share will convert into 4.5 Marvell shares at a fixed ratio, equal to about $1,132 a share and a premium of roughly 23.9% to each company’s unaffected closing price on October 28. Marvell holders will own about 67% of the combined company on a fully diluted basis, and Lumentum holders about 33%. The boards of both companies approved the agreement unanimously.
Matt Murphy will remain chairman and chief executive of the enlarged company. Three Lumentum directors, including CEO Michael Hurlston, will join Marvell’s seven-member board. Closing is expected in the first half of calendar 2028, subject to shareholder votes, regulatory approvals and customary conditions.
The companies put the combined addressable market at $550 billion and said they see more than $1 billion in annual run-rate cost synergies. They expect the deal to add to Marvell’s non-GAAP earnings per share in the first year after closing. Murphy called the transaction an opportunity that comes along once in a generation, citing the shift toward optical connectivity in AI data centers.
Marvell also issued preliminary fiscal third-quarter revenue consistent with its prior guidance, narrowing its range to plus or minus 2%.
The market reaction followed a pattern set last week, when reports of advanced talks sent Marvell shares down by double digits while Lumentum rose. Because the consideration is paid entirely in Marvell stock and the ratio is fixed, any decline in Marvell’s price reduces the value delivered to Lumentum holders, and Lumentum’s own drop on the announcement reflected that exposure.
Analyst responses were mixed. UBS kept its Buy rating and $350 price target on Marvell after the announcement, while others flagged the size of the premium, the dilution to existing Marvell holders and the length of the path to closing.
The release did not disclose a termination fee or any financing arrangements, and it gave no standalone revenue figures for either company. The roughly two-year timetable to closing leaves the transaction exposed to both companies’ share-price swings and to antitrust reviews in multiple jurisdictions, none of which the companies have named.
Sources: Bloomberg, Yahoo Finance, gurufocus.com, Investing.com.









